IFNA1 and melanoma: Moreover, subsets of BRAFV600E metastatic melanoma cells that display a “native immune gene signature” suggestive of IFN pathway activation, have enhanced BRAFi resistance and sensitivity to inhibition of protein kinases involved in IFN induction [224].